de Vries Lentsch, S., Garrelds, I. M., Danser, A. H. J., Terwindt, G. M., & MaassenVanDenBrink, A. (2022). Serum CGRP in migraine patients using erenumab as preventive treatment. Journal of headache and pain, 23(1), 120-7. https://doi.org/10.1186/s10194-022-01483-z
Chicago-Zitierstil (17. Ausg.)de Vries Lentsch, Simone, Ingrid M. Garrelds, A. H. Jan Danser, Gisela M. Terwindt, und Antoinette MaassenVanDenBrink. "Serum CGRP in Migraine Patients Using Erenumab as Preventive Treatment." Journal of Headache and Pain 23, no. 1 (2022): 120-7. https://doi.org/10.1186/s10194-022-01483-z.
MLA-Zitierstil (9. Ausg.)de Vries Lentsch, Simone, et al. "Serum CGRP in Migraine Patients Using Erenumab as Preventive Treatment." Journal of Headache and Pain, vol. 23, no. 1, 2022, pp. 120-7, https://doi.org/10.1186/s10194-022-01483-z.